Ligand Pharm (LGND)

$73.76 0.52 (0.70%)

16:00 EDT LGND Stock Quote Delayed 30 Minutes

3 Stocks That Smart Investors Should Be Flocking to Now

By Josh Enomoto, InvestorPlace Contributor May 30, 2023

Investors may want to detour away from the obvious trades and consider compelling top stocks for smart investors.

Redditors Are Betting on a $600 Ligand Stock Short Squeeze

How Reddit Sent GameStop Up 2,800% – And 7 Stocks That Could Be Next

7 Unhealthy Biotech Stocks To Sell Before They Sicken Your Portfolio

Volume:

Previous Close -

Market Cap 1.23B

PE Ratio 56.31

EPS 1.31

Volume (Avg. Vol.) 115,027

Day's Range $73.40 - $74.87

52-Week Range $57.77 - $109.00

Dividend & Yield N/A (N/A)

LGND Stock Predictions, Articles, and Ligand Pharm News

From InvestorPlace
From the Web

5 Biotech Stocks to Buy for a Strong Growth Prognosis

By Aaron Levitt, InvestorPlace Contributor Mar 11, 2020

The long-term outlook is rosy for these five biotech stocks. They have the pipelines, partners and marketed drugs to provide years of growth for investors.

7 Stocks That Insiders Are Buying

By Mark Putrino, CMT Jun 25, 2019

Insider buying could be a great bullish indicator for a stock. Insiders sell for many reason, but they only buy for one -- and maybe you should buy too.

10 Risky (But Rewarding) Small-Cap Stocks to Buy Now

By James Brumley, InvestorPlace Feature Writer Apr 5, 2019

These ten stocks aren't exactly household names, but they each deserve a spot in a list of small-cap stocks to buy now for traders that can deal with the risk for the potential of high reward.

10 Triple-A Stocks to Buy for the Rest of 2018

By Louis Navellier, Editor, Growth Investor Nov 21, 2018

Here are some triple-a stocks to buy that are primed to start the new year going strong.

5 Beaten-Down Biotech Stocks to Pick Up from the Wreckage

By Aaron Levitt, InvestorPlace Contributor Oct 17, 2018

After the market's rout, biotech stocks offer a huge value right now. Here are 5 that offer the best opportunities for investors.

Best ETFs for 2018: Don’t Sweat This Quarter for the SBIO ETF

By Todd Shriber, InvestorPlace Contributor Sep 28, 2018

On a year-to-date basis, SBIO still looks good, up 14.30%, or 310 basis points better than the Nasdaq Biotechnology Index. Year-to-date, SBIO is also outpacing the equal-weight S&P Biotechnology Select Industry Index.

The 10 Best Stocks to Buy Right Now

By Louis Navellier, Editor, Growth Investor Sep 24, 2018

These are the 10 best stocks to buy now. Regardless of market conditions, they should continue to climb for years to come.

3 Biotech Stocks Up in the Past Month on Industry Turnaround

By Zacks Investment Research Jun 15, 2018

We take a look at three biotech stocks whose share price has increased in the past month due to as the biotech industry bounced back in the past month after dec....

5 Biotech Stocks to Boost Your Portfolio’s Health This Year

By Zacks Investment Research May 31, 2018

Though the biotech industry is down this year, there are still a few stocks which can strengthen your portfolio. Compare Brokers....

9 Stocks to Buy Instead of Bitcoin

By Louis Navellier, Editor, Growth Investor Mar 1, 2018

Bitcoin may look attractive, but there are stocks to buy with growth potential that you don't have to worry about going broke to own.

10 Stocks to Buy for the Next 15 Years

By Louis Navellier, Editor, Growth Investor Feb 23, 2018

Even if volatility continues to rear its ugly head, these stocks have the earnings and sales growth to last a long time.

5 Big Biotech Stocks To Buy In 2018

By Aaron Levitt, InvestorPlace Contributor Jan 17, 2018

Biotech stocks had a great run in 2017. The new year could have more big gains ahead. Here are 5 top biotech stocks to buy today.

4 Drug Stocks to Buy (CELG, EXEL, LGND, RDHL)

By Zacks Investment Research Feb 7, 2017

Here's a look at 4 drug stocks to buy preferred by analysts who have a deep knowledge and understanding of the industry and its companies.

24 Biotechnology Stocks to Sell Now

By Portfolio Grader Nov 28, 2016

This week, the ratings of 24 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Biggest Movers in Manufacturing Stocks Now – KTOV JUNO CCXI CARA

By Portfolio Grader Sep 27, 2016

The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.

4 Biotechnology Stocks to Buy Now

By Portfolio Grader Sep 19, 2016

The grades of 4 Biotechnology stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.